Phase I CD22 CAR T-cell trial updates

被引：3

作者：

Shah, Nirali N. ^{[1
]}

Shalabi, Haneen ^{[1
]}

Yates, Bonnie ^{[1
]}

Yuan, Constance ^{[1
]}

Qin, Haiying ^{[1
]}

Ombrello, Amanda ^{[2
]}

Wang, Hao-Wei ^{[1
]}

Hoffman, Leah ^{[1
]}

Minh Tran ^{[3
]}

Panch, Sandhya ^{[3
]}

Stetler-Stevenson, Maryalice ^{[1
]}

Jin, Jianjian ^{[1
]}

Mackall, Crystal ^{[4
]}

Highfill, Steve ^{[3
]}

Stroncek, David ^{[3
]}

Fry, Terry J. ^{[5
]}

机构：

[1] NCI, Bethesda, MD 20892 USA

[2] NHGRI, Bethesda, MD 20892 USA

[3] NIH, Bldg 10, Bethesda, MD 20892 USA

[4] Stanford, Palo Alto, CA USA

[5] Univ Colorado, Childrens Hosp Colorado, Denver, CO 80202 USA

来源：

CANCER RESEARCH | 2019年 / 79卷 / 13期

关键词：

D O I：

10.1158/1538-7445.SABCS18-LB-146

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

LB-146

引用

页数：4

共 50 条

[1] Sequential CD22 Targeting Impacts CD22 CAR-T Cell Response
Yates, Bonnie
Shalabi, Haneen
Salem, Dalia
Delbrook, Cynthia
Yuan, Constance M.
Stetler-Stevenson, Maryalice
Fry, Terry J.
Shah, Nirali N.
BLOOD, 2018, 132
[2] CD4/CD8 T-Cell Selection Enhances CD22 CAR-T Cell Transduction and inVivo CAR-T Expansion: Updated Results on Phase I Anti-CD22 CAR Dose Expansion Cohort
Shah, Nirali N.
Highfill, Steven L.
Shalabi, Haneen
Yates, Bonnie
Kane, Eli
Fellowes, Vicki
Delbrook, Cynthia
Ren, Jiaqiang
Jin, Jianjian
Stroncek, David
Fry, Terry J.
BLOOD, 2017, 130
[3] CD4 AND CD8 T-CELL POSITIVE SELECTION INCREASES THE ROBUSTNESS OF THE CD22 CAR T-CELL MANUFACTURING PROCESS
Highfill, S. L.
Jin, J.
Fellowes, V.
Ren, J.
Ramakrishna, S.
Fry, T.
Stroncek, D.
CYTOTHERAPY, 2017, 19 (05) : S14 - S14
[4] CD22 CAR T-cell associated hematologic toxicities, endothelial activation and relationship to neurotoxicity
Jess, Jennifer
Yates, Bonnie
Dulau-Florea, Alina
Parker, Kevin
Inglefield, Jon
Lichtenstein, Dan
Schischlik, Fiorella
Ongkeko, Martin
Wang, Yanyu
Shahani, Shilpa
Cullinane, Ann
Smith, Hannah
Kane, Eli
Little, Lauren
Chen, Dong
Fry, Terry J.
Shalabi, Haneen
Wang, Hao-Wei
Satpathy, Ansuman
Lozier, Jay
Shah, Nirali N.
JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2023, 11 (06)
[5] CD22 CAR T-cell therapy in refractory or relapsed B acute lymphoblastic leukemia
Jing Pan
Qing Niu
Biping Deng
Shuangyou Liu
Tong Wu
Zhiyong Gao
Zhaoli Liu
Yue Zhang
Xiaomin Qu
Yanlei Zhang
Shaohui Liu
Zhuojun Ling
Yuehui Lin
Yongqiang Zhao
Yanzhi Song
Xiyou Tan
Yan Zhang
Zhihui Li
Zhichao Yin
Bingzhen Chen
Xinjian Yu
Ju Yan
Qinlong Zheng
Xuan Zhou
Jin Gao
Alex H. Chang
Xiaoming Feng
Chunrong Tong
Leukemia, 2019, 33 : 2854 - 2866
[6] CD22 CAR T-cell therapy in refractory or relapsed B acute lymphoblastic leukemia
Pan, Jing
Niu, Qing
Deng, Biping
Liu, Shuangyou
Wu, Tong
Gao, Zhiyong
Liu, Zhaoli
Zhang, Yue
Qu, Xiaomin
Zhang, Yanlei
Liu, Shaohui
Ling, Zhuojun
Lin, Yuehui
Zhao, Yongqiang
Song, Yanzhi
Tan, Xiyou
Zhang, Yan
Li, Zhihui
Yin, Zhichao
Chen, Bingzhen
Yu, Xinjian
Yan, Ju
Zheng, Qinlong
Zhou, Xuan
Gao, Jin
Chang, Alex H.
Feng, Xiaoming
Tong, Chunrong
LEUKEMIA, 2019, 33 (12) : 2854 - 2866
[7] CD22 CAR T-cell therapy in refractory or relapsed B acute lymphoblastic leukemia
Jing, P.
Niu, Q.
Deng, B.
Liu, S.
Wu, T.
Gao, Z.
Chang, A. H.
Feng, X.
Tong, C.
EUROPEAN JOURNAL OF IMMUNOLOGY, 2019, 49 : 1723 - 1723
[8] CD4/CD8 T-Cell Selection Affects Chimeric Antigen Receptor (CAR) T-Cell Potency and Toxicity: Updated Results From a Phase I Anti-CD22 CAR T-Cell Trial
Shah, Nirali N.
Highfill, Steven L.
Shalabi, Haneen
Yates, Bonnie
Jin, Jianjian
Wolters, Pamela L.
Ombrello, Amanda
Steinberg, Seth M.
Martin, Staci
Delbrook, Cindy
Hoffman, Leah
Little, Lauren
Ponduri, Anusha
Qin, Haiying
Qureshi, Haris
Dulau-Florea, Alina
Salem, Dalia
Wang, Hao-Wei
Yuan, Constance
Stetler-Stevenson, Maryalice
Panch, Sandhya
Tran, Minh
Mackall, Crystal L.
Stroncek, David F.
Fry, Terry J.
JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (17) : 1938 - +
[9] CD22 CAR T-cell therapy: new hope for patients with large B-cell lymphoma
Schubert, Maria-Luisa
Dreger, Peter
LANCET, 2024, 404 (10450): : 314 - 315
[10] Allogeneic CD19/CD22 CAR T-Cell Therapy for B-Cell Acute Lymphoblastic Leukemia
Phely, Laurent
Hensen, Luca
Faul, Christoph
Ruff, Christer Alexander
Schneider, Dina
Bethge, Wolfgang Andreas
Lengerke, Claudia
JAMA ONCOLOGY, 2024, 10 (06) : 821 - 824

← 1 2 3 4 5 →